Menu
Since the release of the Simplify Prior Authorization white paper, we’ve been working with our sponsors, a new steering committee and working groups to help create a better understanding of the challenges of prior authorization and work towards a better process for patients and other stakeholders.
Prior authorization is typically used by insurers as a manual claim submission and review process for high-cost speciality or high-utilization prescription drugs.
During research for the Simplify Prior Authorization (SPA) white paper in 2020, we learned how the prior authorization (PA) workflow process was impacting prescribers.
During research for the Simplify Prior Authorization (SPA) white paper in 2020, we learned how the prior authorization (PA) process was impacting patients.
On the November 26, 2020 Benefits Breakfast Club webinar experts addressed innovations in oncology and the role of prior authorization (PA), including the many challenges of a largely paper-based PA process.
The Simplify Prior Authorization initiative is an advocate for education about prior authorization (PA) and improvement in current prior authorization practices and processes. If your organization is interested in finding out more, getting involved, or in sponsorship of this important initiative, please contact us via the link below.
